Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D True

Showing results (231-240 of 315) with videos related to

Pageof 32
Sort By:
The Prostate|February 4, 2017
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer TherapeuticsHolly M Nguyen, Robert L Vessella, Colm Morrissey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2023
Visual Assessment of 2-Dimensional Levels Within 3-Dimensional Pathology Data Sets of Prostate Needle Biopsies Reveals Substantial Spatial HeterogeneityCan Koyuncu, Andrew Janowczyk, Xavier Farre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 22, 2010
CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarkerLawrence D True, Hui Zhang, Mingliang Ye, et al.
Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Targeted androgen pathway suppression in localized prostate cancer: a pilot studyElahe A Mostaghel, Peter S Nelson, Paul Lange, et al.
Plos One|September 9, 2014
Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomesRyan R Gordon, Mengchu Wu, Chung-Ying Huang, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2018
Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate CancerLiana B Guedes, Carlos L Morais, Helen Fedor, et al.
Journal of Immunological Methods|January 23, 2004
Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assayS Vuckovic, D Gardiner, K Field, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
Prostate cancer cell phenotypes based on AGR2 and CD10 expressionMelissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
Pageof 32

Showing results (231-240 of 315) with videos related to

Sort By:
Pageof 32
The Prostate|February 4, 2017
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer TherapeuticsHolly M Nguyen, Robert L Vessella, Colm Morrissey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2023
Visual Assessment of 2-Dimensional Levels Within 3-Dimensional Pathology Data Sets of Prostate Needle Biopsies Reveals Substantial Spatial HeterogeneityCan Koyuncu, Andrew Janowczyk, Xavier Farre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 22, 2010
CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarkerLawrence D True, Hui Zhang, Mingliang Ye, et al.
Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Targeted androgen pathway suppression in localized prostate cancer: a pilot studyElahe A Mostaghel, Peter S Nelson, Paul Lange, et al.
Plos One|September 9, 2014
Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomesRyan R Gordon, Mengchu Wu, Chung-Ying Huang, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2018
Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate CancerLiana B Guedes, Carlos L Morais, Helen Fedor, et al.
Journal of Immunological Methods|January 23, 2004
Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assayS Vuckovic, D Gardiner, K Field, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
Prostate cancer cell phenotypes based on AGR2 and CD10 expressionMelissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
Pageof 32